Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2025-12-25 @ 10:15 PM
Study NCT ID:
NCT03467958
Status:
TERMINATED
Last Update Posted:
2025-09-17
First Post:
2018-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-12
First Submit QC Date:
None
Study First Post Date:
2018-03-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-29
Results First Submit QC Date:
None
Results First Post Date:
2025-09-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-29
Last Update Post Date:
2025-09-17
Last Update Post Date Type:
ESTIMATED